Evidence map›Paper›PMID 42259887›Full record

ArticleCommunications biology2026

Structural insights into ubiquitin recognition by USP15 revealed through a covalent activity-based probe.

Bing Liu, Ting Wang, Hui Luo, Lipeng Lang, Xinyi Liu, Zijun Gong, Tao Wang, Wei Cheng, Luocheng Xie, Xingwei Zhang and 2 more

Abstract read
In one paragraph

Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Bing LiuZhejiang Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, PR China. bingliu@hznu.edu.cn.ORCID 0000-0002-6018-998X
Ting WangKey Laboratory of Organosilicon Chemistry and Material Technology, Ministry of Education, Zhejiang Key Laboratory of Organosilicon Material Technology, College of Material, Chemistry and Chemical Engineering, Hangzhou Normal University, Hangzhou, PR China. wangting@hznu.edu.cn.ORCID 0000-0002-6871-470X
Hui LuoSchool of Clinical Medicine, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, PR China.
Lipeng LangZhejiang Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, PR China.
Xinyi LiuZhejiang Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, PR China.
Zijun GongZhejiang Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, PR China.
Tao WangZhejiang Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, PR China.
Wei ChengZhejiang Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, PR China.
Luocheng XieZhejiang Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, PR China.
Xingwei ZhangSchool of Clinical Medicine, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, PR China.
Xianjie FangKey Laboratory of Organosilicon Chemistry and Material Technology, Ministry of Education, Zhejiang Key Laboratory of Organosilicon Material Technology, College of Material, Chemistry and Chemical Engineering, Hangzhou Normal University, Hangzhou, PR China.
Xiaoling XuZhejiang Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, PR China. xuxl@hznu.edu.cn.ORCID 0000-0001-8995-1213

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32201026National Natural Science Foundation of China (National Science Foundation of China) 32471270Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) LQ23C050001Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) RG26C020001
6 · The paper itself

Abstract

Ubiquitin-specific protease 15 (USP15) catalyzes deubiquitination of multiple substrates involved in immune responses and cancer through diverse biological processes. However, its ubiquitin recognition and conformational transition mechanisms remain poorly understood. Here, we report the 2.3 Å crystal structure of the USP15 catalytic domain covalently bound to ubiquitin-propargylamine. This structure reveals that ubiquitin binding induces a conformational switch from an inactive-closed to an active-open state, driven by realignment of the catalytic triad and a hinge-like outward swing of the fingers subdomain. Importantly, we characterize two conserved structural features-an α8 helix and an α3-α4 loop-that are essential for maintaining the functional architecture of USP15 for ubiquitin engagement. Deletion of α8 destabilizes USP15 and abrogates its catalytic activity, while cancer-associated mutation P331S destabilizes the α3-α4 loop, weakens ubiquitin binding, and reduces catalytic efficiency. These previously less-characterized structural elements are critical for the enzymatic activity and structural integrity of USP15 and its paralogues, providing potential targets for selective inhibition of deubiquitinases.

Indexed as

UbiquitinUbiquitin-Specific ProteasesCatalytic DomainCrystallography, X-RayHumansModels, MolecularProtein BindingProtein ConformationUbiquitinUbiquitin-Specific ProteasesUSP15 protein, human

Identifiers

PMID42259887
PMCPMC13582858

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.